Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European Organization for Research and Treatment of Cancer Protocol no. 30924.
Source:http://linkedlifedata.com/resource/pubmed/id/11352955
J. Clin. Oncol.
2001
May
15
19
10
2638-46
